NASCO convened healthcare thought leaders to discuss the opportunities and risks of using artificial intelligence (AI) and generative AI (genAI). Daniel Andrew Carnegie, MD, MPH, MBA, Chief Resident, UNC Preventive Medicine Karl Hightower, C-Suite Technology and Transformation Executive, Catalyst at Wellstar Christopher Kunney, a senior-level health information technology executive and strategist, Managing Partner at IOTECH Consulting David Weeks, NASCO’s Chief Digital and Technology Officer To learn more, read a new article by NASCO’s David Weeks #healthcareAI #AI #genAI
Great insights!
Sounds like an insightful and practical discussion about healthcare AI.
Brain Tumor Survivor, ACHDM & HIMSS Fellow & Ambassador, ForbesBLK, Partner - IOTECH, Morehouse School of Medicine Industry & Faculty-Dignity Health Global Education, HIMSS Changemaker, Podcast Host, CHIME Alumni
7 个月Thank you for inviting me to participate in the panel discussion. I definitely enjoyed the lively discussion on the possibilities and pitfall associated with the deployment of AI in both the payor and provider environments.